Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
SERRA, J; MATIASGUIU, X; CALABUIG, R; GARCIA, P; SANCHO, FJ; LACALLE, JP
SURGICaL GaUZE PSEUDOTUMOR
AM J SURG 155 235-237. .
-
RUIZ, M; TOBON, C; Guiu, XM; ARTIGAS, V; RIUS, X; ALLENDE, L
ACUTE POST-TRaNSPLaNT PaNCREaTITIS
Revista Espanola De Las Enfermedades Del Aparato Digestivo 73 23-26. .
-
MATIASGUIU, X; PERICAS, MG; PIQUERAS, AR; POCH, FJS
MaSSIVE aLCOHOLIC HEPaTIC STEaTOSIS aND aCUTE HEPaTIC-FaILURE
MEDICINA CLINICA 89 576-577. .
-
CLADELLAS, M; ABADAL, ML; BALLESTER, M; OBRADOR, D; CREXELLS, C; MATIASGUIU, X; BORDES, R; BONNIN, O
ENDOMYOCaRDIaL DIaGNOSIS OF CaRDIaC LIPOMaTOSIS
Catheterization And Cardiovascular Diagnosis 13 269-270. .
-
PUIG, L; MARTI, R; MATIASGUIU, X; LECHA, M; GUIX, M
GaSTRIC aDENOCaRCINOMa IN a PaTIENT WITH XERODERMa PIGMENTOSUM
BRITISH JOURNAL OF DERMATOLOGY 113 632-633. .
-
DOMINGO, P; MATIASGUIU, X; SANCHEZ, JM; SANCHO, F
LIMBIC aND MEDULLaRY ENCEPHaLITIS aSSOCIaTED TO BRONCHOGENIC-CaRCINOMa
MEDICINA CLINICA 85 772-772. .
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
